These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 8767168

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes.
    Bergerot I, Fabien N, Maguer V, Thivolet C.
    Clin Exp Immunol; 1995 Nov; 102(2):335-40. PubMed ID: 7586687
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.
    Transplantation; 2009 Jan 27; 87(2):198-206. PubMed ID: 19155973
    [Abstract] [Full Text] [Related]

  • 5. Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes.
    Bergerot I, Fabien N, Maguer V, Thivolet C.
    J Autoimmun; 1994 Oct 27; 7(5):655-63. PubMed ID: 7840857
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice.
    Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J, Makino S, Harada M.
    Eur J Immunol; 1992 Sep 27; 22(9):2387-93. PubMed ID: 1516628
    [Abstract] [Full Text] [Related]

  • 12. Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice.
    Pacheco-Silva A, Bastos MG, Muggia RA, Pankewycz O, Nichols J, Murphy JR, Strom TB, Rubin-Kelley VE.
    Eur J Immunol; 1992 Mar 27; 22(3):697-702. PubMed ID: 1547815
    [Abstract] [Full Text] [Related]

  • 13. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P, Ji RC, Shimoda H, Miura M, Kato S.
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec 27; 281(2):1326-36. PubMed ID: 15386276
    [Abstract] [Full Text] [Related]

  • 14. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M, Yoshimoto K, Wong SF, Tanaka C, Yamaoka T, Sano T, Komagata Y, Miyazaki J, Kikutani H, Itakura M.
    J Clin Invest; 1998 Aug 01; 102(3):499-506. PubMed ID: 9691086
    [Abstract] [Full Text] [Related]

  • 15. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
    Saï P, Rivereau AS.
    Diabetes Metab; 1996 Oct 01; 22(5):341-8. PubMed ID: 8896996
    [Abstract] [Full Text] [Related]

  • 16. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
    Füchtenbusch M, Larger E, Thebault K, Boitard C.
    Horm Metab Res; 2005 Feb 01; 37(2):63-7. PubMed ID: 15778920
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.